THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2016

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2016

MARKETPLACE

New pathology lab products and industry news

Home » Marketplace Archives

Urine test for early bladder cancer diagnosis, 2/17

 

February 2017—Micromedic Technologies introduced CellDetect, a staining assay for the early detection of bladder cancer in urine specimens, to the U.S. market. The assay uses color and morphology to differentiate between normal and malignant cells. By highlighting early changes in neoplastic tumors, the color feature of CellDetect serves as an early indicator of malignancy, enhancing the diagnostic accuracy across all cancer stages. With its high sensitivity for low-grade, early stage tumors, the test provides critical adjunctive information supporting the management of bladder cancer patients, particularly for the early indication of recurrence in patients undergoing routine surveillance. Applying standard cytopathology equipment and processes, CellDetect is compatible with all standard urine smears.

Micromedic Technologies, 972-73-2753450

Print Friendly, PDF & Email
Tags:

X